Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology II1 Apr 2018MP64-10 INFILTRATING CD4+ T CELLS ATTENUATED THE SENSITIVITY OF CHEMOTHERAPY IN PROSTATE CANCER VIA SECRETING CCL5 Peng Xiang, Shuai Hu, Song Jin, Yang Yang, JingDong Sheng, and Jie Jin Peng XiangPeng Xiang More articles by this author , Shuai HuShuai Hu More articles by this author , Song JinSong Jin More articles by this author , Yang YangYang Yang More articles by this author , JingDong ShengJingDong Sheng More articles by this author , and Jie JinJie Jin More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2055AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Management of castration-resistant prostate cancer (CPRC) remains challenging because of the unavoidable emergence of acquired resistance to chemotherapy with docetaxel(Doc). The tumor immune micro-environment as well as their secreted cytokines and growth factors play a substantial role in tumor survival and development of resistance to chemotherapy. Our early study have proved that CD4(+)T cells in prostate tumor micro-environment contribute to prostate cancer(PCa) progression, however, their effects on PCa chemo-sensitivity remained unclear. METHODS CD4+T cell infiltration from post-chemotherapy paraffin embedded specimens was performed by IHC. CRPC cell lines--C4-2, CWR22RV1 and CD4(+) T cell lines--HH and Molt-3 were used in vitro co-culture system. After 48 hours co-culture, the PCa cell chemo-sensitivity were detected by CCK8, Tunel and Western-blot. Various cell cytokine was determined by Cytokine arrays and QPCR. RESULTS We found more CD4+T cell infiltration in tumor area (Figure 1A) than in adjacent normal prostate (Figure 1B) in clinical samples. After co-culture with the CD4+T cells, C4-2 and 22Rv1 cells become more resistant to Doc treatment in a dose-dependent manner ranging from 1 nM to 8 nM (Figure 2A). Tunel results indicated that CD4+T cells protect PCa cells from Doc-induced apoptosis (Figure 2C). Meanwhile, the level of cleaved PARP, another indicator for the apoptotic process were also decreased (Figure 2B). QPCR and Cytokine arrays indicates that after co-culture with PCa CD4+T cells could secrete a significantly higher CCL5 (Figure 3A). Moreover, CCL5 stimulation enhanced PCa resistance to docetaxel(Figure 3B). Anti-ccl5 neutralization antibody could reverse co-culture PCa resistance to docetaxel. CONCLUSIONS CD4+T cells significantly attenuated prostate cancer chemo-sensitivity in vitro. Additionally, CCL5 secreted by CD4+T cells plays a key factor in chemo-therapy resistance. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e853-e854 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Peng Xiang More articles by this author Shuai Hu More articles by this author Song Jin More articles by this author Yang Yang More articles by this author JingDong Sheng More articles by this author Jie Jin More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

[TGF-α increases neuroendocrine differentiation and strengthens chemoresistance in prostate cancer DU145 cells]

Expression of Nkx3.1 Enhances 17 Beta-Estradiol Anti-Tumor Action in PC3 Human Prostate Cancer Cells

Abstract 3185: Expression of DNA Methyltransferase (DNMT) Induced by Transforming Growth Factor-SS (Tgf-SS) Promotes Progress of Prostate Cancer

EIF5A2 Promotes Doxorubicin Resistance in Bladder Cancer Cells Through the TGF-β Signaling Pathway.

[Epidermal Growth Factor Up-Regulates the Mrna Expression of Endothelin-1 and Its Receptors in Prostate Cancer PC-3 Cell Lines].

Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer

Study on the effect of PEDF peptide 44-mer on differentiation of prostate cancer cell line PC-3

Monoamine oxidase A drives neuroendocrine differentiation in prostate cancer

Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines

Enhancing Effect of Isoflavonoid Genistein on Radiosensitivity of DU145 Prostate Cancer Cells

Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling

Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway

The Influence of Neuroendocrine Differentiation on the Growth and Androgen Receptor Expression of Prostate Carcinoma Cells

Abstract 6276: In vitro neuroendocrine differentiation of BPH-1 cells under beta-adrenergic stimulation

TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization

Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers

In vitro neuroendocrine differentiation of BPH-1 cells under beta2 adrenergic receptor stimulation

[Expression of AXL Enhances Docetaxel-Resistance of Prostate Cancer Cells].

[Neutrophil extracellular traps promote the proliferation, invasion and migration of prostate cancer cells by upregulating IL-8 expression in DU145 human prostate cancer cells]

MP64-10 INFILTRATING CD4+ T CELLS ATTENUATED THE SENSITIVITY OF CHEMOTHERAPY IN PROSTATE CANCER VIA SECRETING CCL5

EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer